New assessment lowers figure to 76% after criticism that earlier data was incomplete
Home/FT/AstraZeneca revises down efficacy rate of US Covid-19 vaccine trial FT AstraZeneca revises down efficacy rate of US Covid-19 vaccine trial Financial Times0 Less than a minute Facebook X LinkedIn New assessment lowers figure to 76% after criticism that earlier data was incomplete Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
